These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 31174469

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Quantitative evaluation of subclinical left ventricular dysfunction in patients with type 2 diabetes mellitus by three-dimensional echocardiography.
    Chen X, Guo H, Yang Q, Fang J, Kang X.
    Int J Cardiovasc Imaging; 2020 Jul; 36(7):1311-1319. PubMed ID: 32277320
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Impact of glycemic control on aortic stiffness, left ventricular mass and diastolic longitudinal function in type 2 diabetes mellitus.
    Kozakova M, Morizzo C, Fraser AG, Palombo C.
    Cardiovasc Diabetol; 2017 Jun 17; 16(1):78. PubMed ID: 28623932
    [Abstract] [Full Text] [Related]

  • 8. Impact of Improved Glycemic Control on Cardiac Function in Type 2 Diabetes Mellitus.
    Leung M, Wong VW, Hudson M, Leung DY.
    Circ Cardiovasc Imaging; 2016 Mar 17; 9(3):e003643. PubMed ID: 26962125
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Speckle tracking echocardiography in the diagnosis of early left ventricular systolic dysfunction in type II diabetic mice.
    Li RJ, Yang J, Yang Y, Ma N, Jiang B, Sun QW, Li YJ.
    BMC Cardiovasc Disord; 2014 Oct 08; 14():141. PubMed ID: 25292177
    [Abstract] [Full Text] [Related]

  • 12. Increased myocardial extracellular volume assessed by cardiovascular magnetic resonance T1 mapping and its determinants in type 2 diabetes mellitus patients with normal myocardial systolic strain.
    Cao Y, Zeng W, Cui Y, Kong X, Wang M, Yu J, Zhang S, Song J, Yan X, Greiser A, Shi H.
    Cardiovasc Diabetol; 2018 Jan 04; 17(1):7. PubMed ID: 29301529
    [Abstract] [Full Text] [Related]

  • 13. Additive effect of metabolic dysfunction-associated fatty liver disease on left ventricular function and global strain in type 2 diabetes mellitus patients: a 3.0 T cardiac magnetic resonance feature tracking study.
    Tang X, Shi R, Jiang L, Yan WF, Han PL, Qian WL, Yang ZG, Li Y.
    Cardiovasc Diabetol; 2024 Aug 27; 23(1):317. PubMed ID: 39192259
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Association of left ventricular longitudinal myocardial function with subclinical right ventricular dysfunction in type 2 diabetes mellitus.
    Todo S, Tanaka H, Yamauchi Y, Yokota S, Mochizuki Y, Shiraki H, Yamashita K, Shono A, Suzuki M, Sumimoto K, Tanaka Y, Hirota Y, Ogawa W, Hirata KI.
    Cardiovasc Diabetol; 2021 Oct 23; 20(1):212. PubMed ID: 34688280
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Exercise capacity in diabetes mellitus is predicted by activity status and cardiac size rather than cardiac function: a case control study.
    Roberts TJ, Burns AT, MacIsaac RJ, MacIsaac AI, Prior DL, La Gerche A.
    Cardiovasc Diabetol; 2018 Mar 23; 17(1):44. PubMed ID: 29571290
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.